No Data
Tracking of Hong Kong stock concepts | The Medical Insurance Bureau has announced the new medical insurance catalog. Institutions believe that the golden opportunity to increase the allocation of the pharmaceutical sector has already opened (including con
The National Medical Insurance Bureau has conducted preliminary reviews on 440 pharmaceuticals for this year's medical insurance catalog, which is an increase from last year.
CICC: The pharmaceutical sector has entered a value investment range, focusing on the domestic innovative drug industry chain and going overseas.
China International Capital Corporation released a research report stating that after three years of systematic adjustment, the pharmaceutical sector has entered the range of value investment.
Livzon Pharmaceutical Group Inc. (000513.SZ) has spent a total of 0.172 billion yuan to repurchase 4.8942 million shares.
Livzon Pharmaceutical Group Inc. (000513.SZ) announced that, as of July 31, 2024, the company repurchased a total of 4.8942 million A-shares through centralized bidding trading, accounting for 0.53% of the company's total share capital. The highest purchase price is RMB 36.80/share, and the lowest purchase price is RMB 32.95/share. The total amount of funds used is RMB 0.172 billion yuan (excluding transaction costs).
Livzon Pharma (01513.HK) held a board of directors meeting on August 22 to review and approve the semi-annual results.
Livzon Pharma (01513.HK) announced that the board of directors meeting will be held on Thursday, August 22, 2024, to review and approve the unaudited semi-annual performance of the company and its subsidiaries ending on June 30, 2024, and to handle other matters.
LIVZON PHARMA: Date of Board Meeting
China International Capital Corporation: Peptide production ushers in the opportunities of the times with the rapid expansion of GLP-1.
In terms of the global pattern, Swiss companies are leading in peptide production, while China is the main supplier of GLP-1 active pharmaceutical ingredients.
The Market Doesn't Like What It Sees From Livzon Pharmaceutical Group Inc.'s (SZSE:000513) Earnings YetNo Data
